2019 临床实践指南:抑郁症与特定精神疾病共病的管理

2019-01-30 国外精神科相关专家小组(统称) BMC Psychiatry. 2019 Jan 30;19(1):50.

抑郁症与特定精神疾病共病的药物治疗建议尚缺乏,来自法国的精神病学科专家共同制定了该管理指南,该指南结合了科学证据和临床医生的意见针对抑郁症,共病焦虑,人格障碍或物质使用障碍以及老年抑郁的管理提出指导建议。

中文标题:

2019 临床实践指南:抑郁症与特定精神疾病共病的管理

英文标题:

Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts

发布日期:

2019-01-30

简要介绍:

抑郁症与特定精神疾病共病的药物治疗建议尚缺乏,来自法国的精神病学科专家共同制定了该管理指南,该指南结合了科学证据和临床医生的意见针对抑郁症,共病焦虑,人格障碍或物质使用障碍以及老年抑郁的管理提出指导建议。 

拓展指南:抑郁相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 临床实践指南:抑郁症与特定精神疾病共病的管理)] GetToolGuiderByIdResponse(projectId=1, id=fbc051c001698e08, title=2019 临床实践指南:抑郁症与特定精神疾病共病的管理, enTitle=Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts, guiderFrom=BMC Psychiatry. 2019 Jan 30;19(1):50., authorId=null, author=, summary=抑郁症与特定精神疾病共病的药物治疗建议尚缺乏,来自法国的精神病学科专家共同制定了该管理指南,该指南结合了科学证据和临床医生的意见针对抑郁症,共病焦虑,人格障碍或物质使用障碍以及老年抑郁的管理提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=1320, associationName=国外精神科相关专家小组(统称), associationIntro=, copyright=0, guiderPublishedTime=Wed Jan 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>抑郁症与特定精神疾病共病的药物治疗建议尚缺乏,来自法国的精神病学科专家共同制定了该管理指南,该指南结合了科学证据和临床医生的意见针对抑郁症,共病焦虑,人格障碍或物质使用障碍以及老年抑郁的管理提出指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>抑郁</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=2a53f1c0016e30c8" title="阿戈美拉汀治疗抑郁症临床应用专家建议" target=_blank>阿戈美拉汀治疗抑郁症临床应用专家建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=680481c001638032" title="2018 NAMS/NNDC指南:围绝经期抑郁的评估和治疗" target=_blank>2018 NAMS/NNDC指南:围绝经期抑郁的评估和治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=93e941c0016359e6" title="圣·约翰草提取物片治疗抑郁障碍专家共识" target=_blank>圣·约翰草提取物片治疗抑郁障碍专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=19d8b1c0015628c0" title="2018 AAP指南:基层医疗中青少年抑郁症的管理" target=_blank>2018 AAP指南:基层医疗中青少年抑郁症的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9f0081c00151362e" title="老年期抑郁障碍诊疗专家共识" target=_blank>老年期抑郁障碍诊疗专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E6%8A%91%E9%83%81" target=_blank>有关抑郁更多指南</a></ul>, tagList=[TagDto(tagId=228, tagName=抑郁症), TagDto(tagId=86379, tagName=特定精神疾病), TagDto(tagId=1888, tagName=共病)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8540, appHits=435, showAppHits=17, pcHits=6152, showPcHits=3167, likes=119, shares=14, comments=2, approvalStatus=1, publishedTime=Tue Feb 12 00:02:38 CST 2019, publishedTimeString=2019-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Feb 12 00:02:38 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 19:36:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 临床实践指南:抑郁症与特定精神疾病共病的管理)])
2019 临床实践指南:抑郁症与特定精神疾病共病的管理
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=901607, encodeId=3ac890160ec7, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/e141ddca670e4042bffbf47e00f8d2fd/b6517df71dfe42cb979aacdc454225cc.jpg, createdBy=0c532181739, createdName=12074e34m25(暂无昵称), createdTime=Mon Nov 23 23:25:34 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360559, encodeId=69ae36055981, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Wed Feb 13 17:20:00 CST 2019, time=2019-02-13, status=1, ipAttribution=)]
    2020-11-23 12074e34m25(暂无昵称)

    好好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=901607, encodeId=3ac890160ec7, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/e141ddca670e4042bffbf47e00f8d2fd/b6517df71dfe42cb979aacdc454225cc.jpg, createdBy=0c532181739, createdName=12074e34m25(暂无昵称), createdTime=Mon Nov 23 23:25:34 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360559, encodeId=69ae36055981, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Wed Feb 13 17:20:00 CST 2019, time=2019-02-13, status=1, ipAttribution=)]
    2019-02-13 329523732

    不错

    0